Patients’ preferences for anti-osteoporosis drug treatment : a cross-European discrete-choice experiment
Citation
Hiligsmann , M , Dellaert , B G , Dirksen , C D , Watson , V , Bours , S , Goemaere , S , Reginster , J-Y , Roux , C , McGowan , B , Silke , C , Whelan , B , Diez-Perez , A , Torres , E , Papadakis , G , Rizzoli , R , Cooper , C , Pearson , G & Boonen , A 2017 , ' Patients’ preferences for anti-osteoporosis drug treatment : a cross-European discrete-choice experiment ' , Rheumatology , vol. 56 , no. 7 , pp. 1167-1176 . https://doi.org/10.1093/rheumatology/kex071
Rights
This is a pre-copyedited, author-produced version of an article accepted for publication in Rheumatology following peer review. The version of record Mickaël Hiligsmann, Benedict G. Dellaert, Carmen D. Dirksen, Verity Watson, Sandrine Bours, Stefan Goemaere, Jean-Yves Reginster, Christian Roux, Bernie McGowan, Carmel Silke, Bryan Whelan, Adolfo Diez-Perez, Elisa Torres, Georgios Papadakis, Rene Rizzoli, Cyrus Cooper, Gill Pearson, Annelies Boonen; Patients’ preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment. Rheumatology (Oxford) 2017 kex071. is available online at: https://doi.org/10.1093/rheumatology/kex071.